Showing results (21-30 of 285) with videos related to
Sort By:
Pageof 29
Tissue Engineering. Part A|August 26, 2021
Matrix Hyaluronic Acid and Hypoxia Influence a CD133+ Subset of Patient-Derived Glioblastoma CellsJee-Wei Emily Chen, Sarah Leary, Victoria Barnhouse, et al.Radiation Research|December 27, 2019
Imaging and Dosimetry Study of Inter-fraction Setup Error in a Murine Xenograft Flank Tumor Radiation ModelEmily J Smith, Erik J Tryggestad, Brett L Carlson, et al.Advanced Healthcare Materials|August 3, 2017
Extracellular Hyaluronic Acid Influences the Efficacy of EGFR Tyrosine Kinase Inhibitors in a Biomaterial Model of GlioblastomaSara Pedron, Jacob S Hanselman, Mark A Schroeder, et al.Neuro-Oncology Advances|November 28, 2024
Cell migration simulator-based biomarkers for glioblastomaJay Hou, Mariah McMahon, Tyler Jubenville, et al.International Journal of Radiation Oncology, Biology, Physics|August 28, 2021
Moving Beyond the Standard of Care: Accelerate Testing of Radiation-Drug CombinationsSteven H Lin, Henning Willers, Sunil Krishnan, et al.Journal of Visualized Experiments : Jove|March 16, 2026
Stereotactic Intracranial Implantation of Glioblastoma Patient-derived Xenograft Cell Lines in MiceDanielle M Burgenske, Lauren L Ott, Katrina K Bakken, et al.Biomedicines|July 29, 2023
MDM2 Inhibition in the Treatment of Glioblastoma: From Concept to Clinical InvestigationKarolina I Pellot Ortiz, Julian S Rechberger, Leo F Nonnenbroich, et al.International Journal of Particle Therapy|August 31, 2018
Investigating Dependencies of Relative Biological Effectiveness for Proton Therapy in Cancer CellsMichelle E Howard, Chris Beltran, Sarah Anderson, et al.The Journal of Pharmacology and Experimental Therapeutics|September 11, 2015
Efflux transporters at the blood-brain barrier limit delivery and efficacy of cyclin-dependent kinase 4/6 inhibitor palbociclib (PD-0332991) in an orthotopic brain tumor modelKaren E Parrish, Jenny Pokorny, Rajendar K Mittapalli, et al.Bioorganic & Medicinal Chemistry|December 12, 2001
Novel pyrrolo-quinoline derivatives as potent inhibitors for PI3-kinase related kinasesHairuo Peng, Doeg-Il Kim, Jann N Sarkaria, et al.Pageof 29